The Oncology Institute Inc (TOI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TOI Annual Balance Sheets →
This balance sheet overview for The Oncology Institute Inc spans from Sep 30 2025 to Sep 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TOI/balance-sheets
https://api.csimarket.com/api/v1/companies/TOI/fundamentals
https://api.csimarket.com/api/v1/companies/TOI/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & Short-term Investments0.00
Accounts receivable60.68
Other Receivables, Net, Current0.13
Inventories36.63
Other Current Assets36.90
Prepaid Expense And Other Assets Current3.36
Total Current Assets137.69
Equipment/Property/Plant Net10.59
Goodwill net7.23
Intangible Assets8.87
Deferred, Prepaid and Other Assets, Noncurrent2.48
Other Assets, Noncurrent20.91
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents30.28
Operating Lease Right Of Use Asset22.52
Total Assets187.77
Liabilities
Accounts Payable, Current AC82.09
Accrued Liabilities, Current AC29.34
Long-term Debt, Current Maturities LO5.00
Other Liabilities, Current7.27
Total Current Liabilities123.70
Long-term debt72.52
Total Long-term Debt72.52
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent28.91
Operating Lease Liability Current7.40
Derivative Warrant Liabilities Noncurrent0.10
Total Liabilities225.13
Stockholders' Equity
Treasury Stock Common Value-1.02
Common Stock Value0.01
Additional Paid In Capital Common Stock263.10
Retained Earnings / Accumulated Deficit-299.45
Other Equity0.00
Common Stockholder's Equity-37.36
Total Stockholder's Equity-37.36
Liabilities & Stockholder's Equity187.77
4 historic quarters locked

Sign in to unlock the full The Oncology Institute Inc balance sheet history.

About Starling Oncology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 5, 2026
  • Source: toi-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001799191-26-000023

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI